| Applied Psychological Center, Llc | |
|
2907 Independence St Suite F Cape Girardeau MO 63703-5044 | |
| (573) 334-3329 | |
| (573) 200-7006 |
| Full Name | Applied Psychological Center, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 2907 Independence St, Cape Girardeau, Missouri |
| Authorized Official Name and Position | David M Van Pelt (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 5733343329 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Applied Psychological Center, Llc 2907 Independence St Suite F Cape Girardeau MO 63703-5044 Ph: (573) 334-3329 | Applied Psychological Center, Llc 2907 Independence St Suite F Cape Girardeau MO 63703-5044 Ph: (573) 334-3329 |
| NPI Number | 1003018417 |
|---|---|
| Provider Enumeration Date | 06/05/2007 |
| Last Update Date | 02/10/2014 |
| Medicare PECOS PAC ID | 2961418496 |
|---|---|
| Medicare Enrollment ID | O20060221000721 |
News Archive
The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line , established long ago , turned out to behave a lot like cancer stem cells.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
Nanogen announced today that it was issued U.S. Patent No. 6,824,740, "Apparatus for Active Biological Sample Preparation," by the U.S. Patent and Trademark Office.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003018417 | NPI | - | NPPES |
| 506277102 | Medicaid | MO | |
| 001976787 | Other | MO | CHILD TREATMENT SERVICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (Missouri) | Primary |
| Provider Name | David M Van Pelt |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1821066242 PECOS PAC ID: 0749296283 Enrollment ID: I20060223000075 |
News Archive
The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line , established long ago , turned out to behave a lot like cancer stem cells.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
Nanogen announced today that it was issued U.S. Patent No. 6,824,740, "Apparatus for Active Biological Sample Preparation," by the U.S. Patent and Trademark Office.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 8 days ago
News Archive
The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line , established long ago , turned out to behave a lot like cancer stem cells.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
Nanogen announced today that it was issued U.S. Patent No. 6,824,740, "Apparatus for Active Biological Sample Preparation," by the U.S. Patent and Trademark Office.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 8 days ago
Cape Girardeau Metro Treatment Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 760 S. Kings Highway, Suite F, Cape Girardeau, MO 63703 Phone: 573-335-4333 Fax: 573-335-4345 | |
Neurologic Associates Of Cape Girardeau, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3250 Gordonville Rd Ste 206, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 | |
Saint Francis Clinic Cape Girardeau Kingshighway Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1702 N Kingshighway St, Cape Girardeau, MO 63701 Phone: 573-339-2000 Fax: 573-339-1876 | |
Dale & Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2846 Professional Ct, Cape Girardeau, MO 63703 Phone: 573-803-3137 Fax: 573-803-3137 | |
Associated Counseling Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1221 N Kingshighway St, Imperial Building, Cape Girardeau, MO 63701 Phone: 573-335-7929 Fax: 573-335-6445 | |
Community Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 402 S Silver Springs Rd, Cape Girardeau, MO 63703 Phone: 573-334-1100 |